Clinical Medicine News
-
3 Surprising Benefits of CBD on Skin
3 Surprising Benefits of CBD on Skin With so many benefits of CBD on skin, there are a lot of good reasons to add CBD to your skin care routine. CBD has become incredibly popular for its therapeutic properties. And, in addition to helping with everything from stress and anxiety relief to muscle aches, there is also a lot of evidence pointing to CBD as an effective tool for relieving ...
By Medcbdx
-
Biosceptre Signs Deal With Carina Biotech
Biosceptre is pleased to announce that an agreement has been signed with pre-clinical CAR T development company, Carina Biotech, that will see the advancement of a promising cancer immunotherapy. Biosceptre, a biopharmaceutical company developing targeted therapeutics and immune-oncology products, has acquired the exclusive rights to Carina Biotech’s nfP2X7-targeted CAR-T cells and ...
-
Ivenix Medical Director to Deliver the 2020 Ellison C. Pierce, Jr. Memorial Safety Lecture at Anesthesiology 2020
Ivenix, Inc., a medical technology company with the vision of eliminating infusion-related patient harm, today announced its medical director, Matthew B. Weinger, M.D., M.S., will deliver the 2020 Ellison C. Pierce Memorial Safety Lecture at ANESTHESIOLOGY® 2020, the annual meeting of the American Society of Anesthesiologists (ASA), on Saturday, Oct. 3. Dr. Weinger’s presentation on ...
By Ivenix, Inc.
-
BioPoly Orthopedic Resurfacing Products Enter North America
FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with Canada-based distributor, Verve Medical Products, Inc., to distribute the BioPoly® partial resurfacing family of products throughout Canada, with distribution initially taking place through the Canadian SAP. Verve Medical Products specializes in bringing medical-surgical products to Canada through ...
By BioPoly, LLC
-
BioAesthetics Surpasses Series A Goal Further Advancing the Nipple-Areolar Complex Graft to Clinical Use
BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 million, further advancing its inaugural product — the nipple-areolar complex (NAC) graft, or NACgraftTM, for patients who are undergoing breast reconstruction following breast cancer and mastectomy — to clinical use. BioAesthetics’ Series A was led by a personal ...
-
The world is pivoting due to COVID-19. Should IA as well?
IAIA members were recently able to study the results of the second survey on “Impact of COVID-19 on Impact Assessment,” which was done 29 July – 6 August 2020. This survey has resulted in some data that are troubling for the practice of impact assessment (IA), and may require a focused examination by IAIA and its members. The survey had 700 respondents from across the world. One ...
-
Cyanotech Corporation Launches BioAstin
Cyanotech® Corporation, (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announces its launch of BioAstin® Hawaiian Astaxanthin® in a new delivery form, water dispersible powder, available in both 1% and 2% concentrations. The Nation’s #1 brand of Astaxanthin*, BioAstin, is now offering their new water dispersible ...
-
SurGenTec® Announces First-of-its-Kind FDA Clearance for its 3D GraftRasp System™ Including Key Spine Indications
The 3D GraftRasp System is the only device to receive FDA clearance that allows for both decortication of bone and the delivery of autograft, allograft or synthetic bone graft. It is approved for general orthopedic use and spine procedures. “In spine procedures, the transverse processes and facet joints may now be targeted in a more efficient and effective surgical technique pioneered by ...
-
Silk Road Medical Names Rick Anderson to Board of Directors
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors. Anderson brings over 30 years of senior executive leadership experience in the medical device industry. He is the Chairman and Managing Director of Revival Healthcare Capital, a ...
-
Alucent Biomedical Announces $35 Million Series B Financing Led By A Multinational Strategic Investor
Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced the close of a $35 million Series B financing round led by a large multinational strategic investor and joined by another new investor, Fresenius Medical Care Ventures. Alucent was founded by the Avera Research Institute, an arm of Avera Health, which also ...
-
Acurable launches groundbreaking technology to diagnose sleep apnoea remotely
Acurable, a fast-growing medical device company, has announced the availability of its first product, AcuPebble SA100, a small wearable device which for the first time enables a fully automated and remote diagnosis of obstructive sleep apnoea (OSA). Traditionally, the diagnosis of OSA has required multiple hospital visits for patients, and doctors have had to manually review and analyse data from ...
-
Atmo Biosciences signs deal with RMIT University to commercialize ingestible gas-sensing capsule for gut health
Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule. The Atmo Gas Capsule is set to revolutionize how doctors diagnose and treat common gastrointestinal (GI) disorders by offering a non-invasive, low-cost, and more accurate alternative to current technologies. Patients with ...
-
Identifying Respiratory Irritants, Allergens and Known Asthma Triggers to Mitigate Occupational Asthma Risks
Occupational asthma, also known as work-related asthma, can dramatically impact a worker’s quality of life and reduce their productivity. Sadly, it’s the most common occupational lung disease in the United States and the condition increases costs to employees, employers and society. As an example, inhalation exposure to something as basic as flour dust can cause a condition known as ...
-
Cytex Awarded CRP Award for First-In-Human Pilot Trial
Cytex is thrilled to announce the receipt of a Commercialization Readiness Pilot Program Award from the National Institute of Health entitled “Cartilage Regeneration with Tunable Inflammation Resistance.” The goal of this project is to prepare for and then conduct a First-In-Human pilot clinical trial that will test the safety of Cytex’s innovative hip implant. Cytex is ...
-
Cytex Awarded CRP Award for First-In-Human Pilot Trial
Cytex is thrilled to announce the receipt of a Commercialization Readiness Pilot Program Award from the National Institute of Health entitled “Cartilage Regeneration with Tunable Inflammation Resistance.” The goal of this project is to prepare for and then conduct a First-In-Human pilot clinical trial that will test the safety of Cytex’s innovative hip implant. Cytex is ...
-
Flottweg Academy’s 5th Anniversary:
In just five years, the Flottweg Academy established itself as a well recognised and top-performing institution. Both our employees and international customers meet at the Academy, allowing it to be a place for teamwork where we strive for mutual success. With a total of more than 260 customer training days and record revenues alone in 2019, customer training has become one of the cornerstones ...
By Flottweg SE
-
Medtronic to Acquire Avenu Medical
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Avenu Medical, a privately held medical device company based in San Juan Capistrano, Calif. focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis. Terms of the transaction were not ...
-
U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce that oral arguments for the company’s court case USA v. U.S. Stem Cell Clinic, et al has been set for the docket beginning January 11, 2021. Since May 9, 2018, U.S. Stem Cell Inc., as one of the parties named, has been challenged ...
-
iXensor’s newly launched product, PixoTest® COVID -19 Antigen Self-Test Kit, could detect the COVID -19 major strain Omicron BA.5, combining the self-reporting function of PixoHealth App, leading to a safe, secured, and protected social new normal
iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era of “self-initiated epidemic prevention”. The latest study of variant ...
By iXensor
-
Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease
Oxford Brain Diagnostics Ltd, a spinout from the University of Oxford specialising in the measurement of neurodegeneration in Alzheimer’s disease, today announces that the US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to its Cortical Disarray Measurement (CDM®) Software Device for evaluating adults at risk of Alzheimer’s disease Oxford Brain ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you